Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Genetically modified pertussis toxin: a quantum leap?

McIntyre PB, Edwards KM.

Lancet Infect Dis. 2018 Nov;18(11):1169-1171. doi: 10.1016/S1473-3099(18)30426-2. Epub 2018 Sep 25. No abstract available.

PMID:
30266328
3.

Investigating pertussis toxin and its impact on vaccination.

Coutte L, Locht C.

Future Microbiol. 2015;10(2):241-54. doi: 10.2217/fmb.14.123. Review.

PMID:
25689536
4.

Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin.

Williams MM, Sen K, Weigand MR, Skoff TH, Cunningham VA, Halse TA, Tondella ML; CDC Pertussis Working Group.

Emerg Infect Dis. 2016 Feb;22(2):319-322. doi: 10.3201/eid2202.151332.

5.

Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.

Marsili I, Pizza M, Giovannoni F, Volpini G, Bartalini M, Olivieri R, Rappuoli R, Nencioni L.

Infect Immun. 1992 Mar;60(3):1150-5.

6.

Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination.

Thomas MG, Redhead K, Lambert HP.

J Infect Dis. 1989 Feb;159(2):211-8.

PMID:
2536779
7.

[Pathogenetic significance of Bordetella pertussis toxin].

Finger H.

Immun Infekt. 1985 Apr;13(2):47-9. German. No abstract available.

PMID:
2860059
9.

[Engineering of attenuated Bordetella pertussis bacteria producing immunogenic non-toxic form of pertussis toxin].

Siniashina LN, Nechaeva EV, Amelina IP, Karataev GI.

Zh Mikrobiol Epidemiol Immunobiol. 2009 Nov-Dec;(6):89-94. Russian.

PMID:
20095432
10.

Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland.

Barkoff AM, Mertsola J, Guillot S, Guiso N, Berbers G, He Q.

Clin Vaccine Immunol. 2012 Oct;19(10):1703-4. Epub 2012 Aug 22. No abstract available.

11.

[Modern strains of Bordetella pertussis: immunobiological properties and vaccine improvement].

Shinkarev AS, Mertsalova NU, Mazurova IK, Borisova OIu, Zakharova NS, Ozeretskovskaia MN, Zaĭtsev EM, Poddubikov AV, Britsina MV, Bazhanova IG.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):20-5. Russian.

PMID:
17886371
12.

Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.

Dalby T, Petersen JW, Harboe ZB, Krogfelt KA.

J Med Microbiol. 2010 Sep;59(Pt 9):1029-36. doi: 10.1099/jmm.0.020826-0. Epub 2010 May 27.

PMID:
20508003
14.

Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines.

Seubert A, D'Oro U, Scarselli M, Pizza M.

Expert Rev Vaccines. 2014 Oct;13(10):1191-204. doi: 10.1586/14760584.2014.942641. Epub 2014 Sep 3. Review.

PMID:
25183193
15.

Development and clinical testing of an acellular pertussis vaccine containing genetically detoxified pertussis toxin.

Rappuoli R, Pizza M, De Magistris MT, Podda A, Bugnoli M, Manetti R, Nencioni L.

Immunobiology. 1992 Feb;184(2-3):230-9. Review.

PMID:
1587545
16.

Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children.

von Linstow ML, Pontoppidan PL, von König CH, Cherry JD, Hogh B.

Eur J Pediatr. 2010 Sep;169(9):1119-22. doi: 10.1007/s00431-010-1192-9. Epub 2010 Apr 8.

17.

Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?

Mooi FR, van Loo IH, King AJ.

Emerg Infect Dis. 2001;7(3 Suppl):526-8.

18.

[A polyvalent complex of Bordetella pertussis antigens as the basis for an acellular pertussis vaccine].

Zakharova NS, Shmeleva EI, Remova TN, Bazhanova IG, Ozeretskovskaia MN, Mertsalova NU, Britsina MV, Ermolova EV, Zaĭtsev EM.

Zh Mikrobiol Epidemiol Immunobiol. 1997 May-Jun;(3):70-2. Russian.

PMID:
9304336
19.

[Immunobiologic activity of Bordetella pertussis strains defective in various virulence factors].

Smirnov VD, Chuprinina RP, Siundiukova RA, Maksiutov RV.

Zh Mikrobiol Epidemiol Immunobiol. 1989 Mar;(3):8-10. Russian.

PMID:
2545060
20.

Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.

Taranger J, Trollfors B, Bergfors E, Knutsson N, Lagergård T, Schneerson R, Robbins JB.

Pediatrics. 2001 Dec;108(6):E115. Review.

PMID:
11731642

Supplemental Content

Support Center